Bicara Therapeutics Inc. (BCAX) Institutional Ownership Changes & 13F Activity
Bicara Therapeutics Inc. (BCAX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Citadel Advisors Llc, Omega Fund Management, Llc, Price T Rowe Associates Inc, Orbimed Advisors Llc, and Ameriprise Financial Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -18,111 | -20.1% | 72,174 | $2.14M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -1,448,200 | -87.3% | 211,142 | $6.27M | Q2 2026 | Sep 02, 2026 |
| Allianz Asset Management Gmbh | Buy | +17,200 | — | 17,200 | $510.67K | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +36,683 | — | 36,683 | $1.09M | Q2 2026 | Aug 27, 2026 |
| Optimize Financial Inc | Sell | -83 | -0.3% | 23,913 | $709.98K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +22,077 | +130.5% | 39,000 | $1.16M | Q2 2026 | Aug 24, 2026 |
| Omega Fund Management, Llc | Sell | -570,000 | -23.8% | 1,822,150 | $54.10M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +528,050 | +38.4% | 1,904,248 | $56.54M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Sell | -476,200 | -71.4% | 191,100 | $5.67M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +288,749 | — | 288,749 | $8.57M | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Sell | -267,293 | -4.0% | 6,338,487 | $188.19M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +221,250 | +79.9% | 498,193 | $14.79M | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Sell | -175,000 | -3.2% | 5,250,000 | $155.87M | Q2 2026 | Aug 14, 2026 |
| Dafna Capital Management Llc | Sell | -136,778 | -32.4% | 284,955 | $8.46M | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Sell | -128,703 | -55.1% | 105,000 | $3.12M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +105,552 | +67.4% | 262,254 | $7.79M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +101,496 | +38.4% | 365,481 | $10.85M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Sell | -59,233 | -14.8% | 342,211 | $10.16M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +59,220 | — | 59,220 | $1.76M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +58,983 | — | 58,983 | $1.75M | Q2 2026 | Aug 14, 2026 |
| Burkehill Global Management, Lp | Sell | -50,000 | -50.0% | 50,000 | $1.48M | Q2 2026 | Aug 14, 2026 |
| Rock Springs Capital Management Lp | Buy | +46,191 | +9.4% | 535,286 | $15.89M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +43,389 | — | 43,389 | $1.29M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -43,275 | -48.1% | 46,606 | $1.38M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -38,397 | -6.9% | 520,567 | $15.46M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +37,500 | +0.9% | 4,100,000 | $121.73M | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +24,916 | +166.4% | 39,893 | $1.18M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +24,915 | +7.6% | 352,904 | $10.48M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +24,629 | +175.7% | 38,646 | $1.15M | Q2 2026 | Aug 14, 2026 |
| Alliancebernstein L.P. | Buy | +24,160 | +75.9% | 55,990 | $1.11M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about BCAX activity
Which institutional owners are buying BCAX?
Institutional owners buying BCAX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BCAX activity?
"Buy" means an investor increased their reported position in BCAX compared to the prior reporting period. This reflects growing exposure to Bicara Therapeutics Inc. (BCAX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BCAX increasing?
Institutional interest in BCAX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.